Industry Partners

We would like to thank the following companies and organizations for their continued support



As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focused on a single purpose: to enable people with life-altering conditions to lead better lives. The company has high standards and a list of must-follow rules (can be seen at

Shire is a global company with offices in the major pharmaceutical markets. Its UK offices are in Basingstoke and its US offices are in Wayne, Pennsylvania.


One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since its founding in 1981, the company has introduced breakthrough treatments across several areas of medicine that have provided new hope for patients. Today, approximately 10,000 Genzyme employees serve patients in nearly 100 countries.


Amicus Therapeutics is pioneering a paradigm-shifting approach to treating a range of human genetic diseases in which crucial proteins are misfolded, thus reducing or eliminating their functionality. Amicus develops pharmacological chaperones - oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. This novel, next-generation approach offers the potential to improve treatment options for patients with genetic diseases.


IISC is a non-profit organisation that partners with individuals, organizations and communities to achieve greater social impact. It dows this trough providing training, facilitation and coaching services to the public and not-for-profit sectors.

Sanders and Clients BV

 is a Dutch company that deliver equipment to infuse the medicine.


Actelion is a global, independent biopharmaceducial company discovering, developing and marketing innovative drugs for high unmet medical needs.